Summit Global Investments

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1697953 BOUNTIFUL, UT

Position in UTHR

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,009,429

-$2,499,233 QoQ

Shares Held

1,863

-68.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#463

of 874 holders

Holding Since

Dec 2020

14 quarters on record

Healthcare · as of Jun 30, 2026

Summit Global Investments holds $8,262,843 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	29,424	$4,959,120
2	TAK	Takeda Pharmaceutical Co Ltd	89,173	$1,429,443
3	UTHR	UNITED THERAPEUTICS Corp This page	1,863	$1,009,429
4	PAHC	Phibro Animal Health Corp	10,958	$344,081
5	ALKS	Alkermes plc.	6,001	$314,452
6	SUPN	Supernus Pharmaceuticals, Inc.	4,436	$206,318

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,009,429	1,863	-68.5%	Shares	Sole	2026-08-03
2026-03-31	$3,508,662	5,917	-3.9%	Shares	Sole	2026-05-07
2025-12-31	$2,999,511	6,156	-59.0%	Shares	Sole	2026-02-18
2025-09-30	$6,290,665	15,006	-18.1%	Shares	Sole	2025-11-03
2025-06-30	$5,267,987	18,333	+30.4%	Shares	Sole	2025-08-12
2025-03-31	$4,333,659	14,058	-61.0%	Shares	Sole	2025-04-07
2024-12-31	$12,730,820	36,081	-27.8%	Shares	Sole	2025-02-11
2024-09-30	$17,917,141	49,999	-6.8%	Shares	Sole	2024-10-31
2024-06-30	$17,096,897	53,671	-27.1%	Shares	Sole	2024-07-22
2024-03-31	$16,923,472	73,670	+171.7%	Shares	Sole	2024-04-29
2023-12-31	$5,961,657	27,112	+80.5%	Shares	Sole	2024-02-06
2023-09-30	$3,391,889	15,017	+838.6%	Shares	Sole	2023-10-16
2021-03-31	$267,632	1,600	-20.0%	Shares	Sole	2022-01-27
2020-12-31	$303,580	2,000	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.